HHMI Expands Under New President

WASHINGTON—The Howard Hughes Medical Institute (HHMI) next month will announce a $40 million-a-year program ranging from support for graduate training in the biomedical sciences to funding of health policy and cost-containment studies. Purnell Choppin, HHMI’s former vice president and chief scientific officer who was appointed president of the institute on September 1, said the education prograin will include funds to upgrade science departments at undergraduate colleges and sup

Written byRon Cowen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—The Howard Hughes Medical Institute (HHMI) next month will announce a $40 million-a-year program ranging from support for graduate training in the biomedical sciences to funding of health policy and cost-containment studies.

Purnell Choppin, HHMI’s former vice president and chief scientific officer who was appointed president of the institute on September 1, said the education prograin will include funds to upgrade science departments at undergraduate colleges and support for short courses in ethics and other subjects at scientific conferences. Funding for the biomedical education program—a major expansion of HHMI’s activities in this area— represents more than a third of the National Science Foundation’s entire $99 million science education budget for this year.

The new program will also support graduate training at non-academic research institutions, noted George Thorn, chairman of HHMI’s trustees. Thorn and other institute staff members said the new graduate student fellowships will be modeled on NSF fellowships and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies